“Much to Be Proud Of”In an email to employees, titled, “A BIG thank you,” DePinho lauded the high response rate, saying that the survey scores were favorable.
In a long-awaited survey of employees at MD Anderson Cancer Center, faculty members show a significant drop in approval scores for the administration's executive leadership, in comparison with the last time the survey was administered in 2012.
THE ONCOLOGY NURSING SOCIETY announced its 2014-2015 board of directors at its 39th Annual Congress.
THE CHILDREN'S ONCOLOGY DRUG ALLIANCE is joining the research and resources of the University of New South Wales and its commercialization arm, NewSouth Innovations; The Kids' Cancer Project, an Australia-based childhood cancer research charity; Novogen, an Australian oncology drug development company; and Nationwide Children's Hospital in Columbus, Ohio, to help accelerate development of a therapeutic approach to neuroblastoma.
MOFFITT CANCER CENTER began a collaboration with Vermillion Inc. to produce clinical and economic data to support a new value-based practice model that may improve survival, quality of life and cost-effectiveness of care for patients with ovarian cancer.
BRISTOL-MYERS SQUIBB and Celldex Therapeutics Inc. entered into a clinical trial collaboration to evaluate the safety, tolerability and preliminary efficacy of nivolumab, BMS's investigational PD-1 immune checkpoint inhibitor, and varlilumab, Celldex's CD27 targeting investigational antibody in a phase I/II study.
THE AMERICAN COLLEGE OF RADIOLOGY named new officers during its 91st Annual Meeting and Chapter Leadership Conference.
The Translational Genomics Research Institute and George Mason University announced a strategic research alliance May 6.
The 340B drug discount program is causing a rise in the costs of treating cancer patients, according to a new report.
AAUP: “Term Tenure” is “Oxymoronic”MD Anderson's “term tenure” system is not tenure, AAUP said.
